A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii

被引:142
作者
Sheng, Wang-Huei [1 ,2 ]
Liao, Chun-Hsing [2 ]
Lauderdale, Tsai-Ling [3 ]
Ko, Wen-Chien [4 ]
Chen, Yao-Shen [5 ]
Liu, Jien-Wei [6 ]
Lau, Yeu-Jun [7 ]
Wang, Li-Hsin [8 ]
Liu, Ke-Sun [9 ]
Tsai, Tung-Yuan [10 ]
Lin, San-Yi [11 ]
Hsu, Meng-Shiuan [2 ]
Hsu, Le-Yin [1 ]
Chang, Shan-Chwen [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan
[3] Natl Hlth Res Inst, Div Clin Res, Zhunan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan
[5] Vet Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan
[6] Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan
[7] Show Chwan Mem Hosp, Dept Internal Med, Changhua, Taiwan
[8] Buddhist Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan
[9] Chung Shan Med Coll Hosp, Dept Internal Med, Taipei, Taiwan
[10] Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan
[11] St Marys Hosp, Dept Internal Med, Lo Tung, Taiwan
关键词
Acinetobacter baumannii; Carbapenem resistance; Nosocomial infection; Mortality; INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTION; ANTIMICROBIAL RESISTANCE; ILL PATIENTS; OUTBREAK; SURVEILLANCE; ACQUISITION; BACTEREMIA; PROGNOSIS; BACTERIAL;
D O I
10.1016/j.ijid.2010.02.2254
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Risk factors and outcome in patients who acquire nosocomial infections due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated. Methods: A multicenter retrospective study was conducted to analyze the clinical and microbiological data of patients with nosocomial infections due to A. baumannii in 10 hospitals around Taiwan from May 2004 to December 2006. Comparisons were made between patients with infections due to CRAB and patients with infections due to carbapenem-susceptible A. baumannii (CSAB). Results: One hundred and twenty-one patients carrying CRAB (infections, n = 91) and 127 patients carrying CSAB (infections, n = 97) were recruited for analysis. Compared with patients with CSAB infections, patients with CRAB infections had a longer duration of hospital stay before A. baumannii was isolated (median 48 vs. 21 days, p < 0.001) and were more likely to have had exposure to a carbapenem (adjusted odds ratio (AOR) 2.57, 95% confidence interval (95% CI) 1.43-5.35; p = 0.02) and an intensive care unit (ICU) stay (AOR 3.42, 95% CI 1.76-5.26; p = 0.008). Risk factors associated with CRAB bacteremia included duration of hospital stay before onset of bacteremia (AOR 1.009 per 1-day longer, 95% CI 1.03-1.24; p = 0.049), prior colonization with A. baumannii (AOR 3.27, 95% CI 1.99-5.93; p = 0.002), and hospitalization in the ICU (AOR 6.12, 95% CI 1.58-13.68; p = 0.009). Patients with CRAB bacteremia had a higher mortality rate than patients with CSAB bacteremia (46.0% vs. 28.3%, p = 0.04). Multivariate analysis showed that carbapenem resistance (AOR 5.31, 95% CI 1.88-13.25; p = 0.002), central venous catheterization (AOR 3.27, 95% CI 1.55-10.56; p = 0.009), and ICU stay (AOR 2.56, 95% CI 1.15-8.85; p = 0.04) were independent variables associated with mortality in patients with A. baumannii bacteremia. Conclusions: Patients with CRAB infections have a higher mortality rate than those with CSAB infections. Longer hospital stay, colonization with A. baumannii, and admission to the ICU were associated with the development of CRAB bacteremia. (C) 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E764 / E769
页数:6
相关论文
共 36 条
[1]   Worldwide emergence of carbapenem-resistant Acinetobacter spp. [J].
Afzal-Shah, M ;
Livermore, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) :576-577
[2]   Risk factor's for ICU-acquired imipenem-resistant Gram-negative bacterial, infections [J].
Akinci, E ;
Çollan, A ;
Bodur, H ;
Balaban, N ;
Erbay, A .
JOURNAL OF HOSPITAL INFECTION, 2005, 59 (04) :317-323
[3]   Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections [J].
Baran, Guelseren ;
Erbay, Ayse ;
Bodur, Huerrem ;
Onguru, Pinar ;
Akinci, Esraguel ;
Balaban, Neriman ;
Cevik, Mustafa A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01) :16-21
[4]  
Choi Sang-Ho, 2006, Journal of Infection and Chemotherapy, V12, P380, DOI 10.1016/S1341-321X(06)70898-4
[5]   Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain:: a nationwide study [J].
Cisneros, JM ;
Rodríguez-Baño, J ;
Fernández-Cuenca, F ;
Ribera, A ;
Vila, J ;
Pascual, A ;
Martínez-Martínez, L ;
Bou, G ;
Pachón, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (11) :874-879
[6]  
Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI
[7]   Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Montero, A ;
Pujol, M ;
Domínguez, MA ;
Ayats, J ;
Argerich, MJ ;
Garrigosa, F ;
Ariza, J ;
Gudiol, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :4086-4095
[8]   An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients [J].
Fierobe, L ;
Lucet, JC ;
Decré, D ;
Muller-Serieys, C ;
Deleuze, A ;
Joly-Guillou, ML ;
Mantz, J ;
Desmonts, JM .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (01) :35-40
[9]   Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients:: Geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) [J].
Gales, AC ;
Jones, RN ;
Forward, KR ;
Liñares, J ;
Sader, HS ;
Verhoef, J .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S104-S113
[10]   Acinetobacter baumannii ventilator-associated pneumonia:: epidemiological and clinical findings [J].
Garnacho-Montero, J ;
Ortiz-Leyba, C ;
Fernández-Hinojosa, E ;
Aldabó-Pallás, T ;
Cayuela, A ;
Marquez-Vácaro, JA ;
Garcia-Curiel, A ;
Jiménez-Jiménez, FJ .
INTENSIVE CARE MEDICINE, 2005, 31 (05) :649-655